Myopathy with anti-Jo-1 antibodies: pathology in perimysium and neighbouring muscle fibres | Journal of Neurology, Neurosurgery & Psychiatry
Main Characteristics of Anti Jo-1 Patients at Disease Onset According... | Download Table
Frontiers | Description and Analysis of a Novel Subtype of the Anti-Synthetase Syndrome Characterized by Frequent Attacks of Fever and Systemic Inflammation in a Single-Center Cohort Study
Antisynthetase Syndrome (AS) - Myositis Support and Understanding
Anti-OJ autoantibodies: Rare or underdetected? - ScienceDirect
Comparison of long-term outcome between anti-Jo1- and anti-PL7/PL12 positive patients with antisynthetase syndrome. | Semantic Scholar
Anti-Synthetase (Anti-Jo-1) Autoantibodies - YouTube
A unique autoantibody pattern of positive anti-Jo-1, anti-U1RNP, and antiproteasome antibodies in autoimmune myositis as a diagnostic challenge | Annals of the Rheumatic Diseases
Interstitial lung disease is a dominant feature in patients with circulating myositis-specific antibodies | BMC Pulmonary Medicine | Full Text
Outcomes of anti-Jo1 patients with antisynthetase syndrome a | Download Table
SciELO - Brasil - Síndrome antissintetase anti-Jo-1 Síndrome antissintetase anti-Jo-1
Frequency of anti-Jo-1 and smoking status by country | Download Table
What does it mean if a patient is positive for... | F1000Research
Barone Mnemonic: Dermatomyositis
AC Anti JO-1 - Laboratorio Médico Samalab
Main Features of Anti Jo-1 Patients at Last Follow-Up Available... | Download Table
Patients with anti-Jo1 antibodies display a characteristic IgG Fc-glycan profile which is further enhanced in anti-Jo1 autoantibodies | Scientific Reports
Rheumatologic Tests: A Primer for Family Physicians | AAFP
Differences in the Clinical Characteristics and 1-Year Mortality Rates of Patients with Dermatomyositis with anti-Jo-1 and anti-MDA5 Antibodies
SocvenezolanaReumato on X: "El anti-Jo-1 es el Ac anti- sintetasa mas comun y se correlaciona #miositis, enfermedad pulmonar #artritis y mano de mecanico #reumatologia https://t.co/UXlT1v9DUw" / X
